The estimated Net Worth of Kevin M Mcmullen is at least $6.97 Milión dollars as of 9 November 2015. Kevin Mcmullen owns over 8,000 units of Steris Plc stock worth over $6,375,376 and over the last 20 years Kevin sold STE stock worth over $589,840.
Kevin has made over 8 trades of the Steris Plc stock since 2011, according to the Form 4 filled with the SEC. Most recently Kevin sold 8,000 units of STE stock worth $589,840 on 9 November 2015.
The largest trade Kevin's ever made was exercising 120,000 units of Steris Plc stock on 23 March 2012 worth over $498,000. On average, Kevin trades about 10,991 units every 42 days since 2004. As of 9 November 2015 Kevin still owns at least 26,338 units of Steris Plc stock.
You can see the complete history of Kevin Mcmullen stock trades at the bottom of the page.
Kevin's mailing address filed with the SEC is 175 GHENT ROAD, , FAIRLAWN, OH, 44333-3300.
Over the last 9 years, insiders at Steris Plc have traded over $157,726,045 worth of Steris Plc stock. The most active insiders traders include Richard Martin Steeves, Walter M Jr Rosebrough a John P Wareham. On average, Steris Plc executives and independent directors trade stock every 19 days with the average trade being worth of $3,374,074. The most recent stock trade was executed by Christopher S Holland on 8 August 2024, trading 473 units of STE stock currently worth $113,369.
steris is a leading provider of infection prevention and procedural surgical products and services, focused primarily on healthcare, pharmaceutical, research and medical device customers. our mission is to provide a healthier today and a safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services. while the corporation was founded as innovative medical technologies in 1985 and renamed steris in 1987, our history dates back to 1894 with the founding of american sterilizer company, a long-time, global leading innovator of sterilization products. today, through a series of strategic acquisitions and continual innovation of new products, steris holds one of the broadest portfolios of products in the industry. it stands at the forefront of efforts to prevent infection and contamination in healthcare, pharmaceutical and medical device environments.
Steris Plc executives and other stock owners filed with the SEC include: